Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHAPIRO, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SHAPIRO, E.
(Chest. 1959;35:95-98.)
© 1959 American College of Chest Physicians

CURRENT THERAPY

Reasons for the Unsettled State of the Anticoagulant Controversy

EDWARD SHAPIRO M.D.

We remain in a quandary. We treat a disease of the coronary arteries of unknown origin with a drug that might not even be antithrombotic. For all we know, what we today term acute myocardial infarction may turn out to be several distinct diseases, each requiring different treatment.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1959 by the American College of Chest Physicians.